These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2161145)

  • 21. Redirecting retroviral tropism by insertion of hepatitis B virus PreS1 core peptide into the envelope.
    Qi P; Han JX; Lu YQ; Wang CX
    Arch Virol; 2007; 152(9):1721-30. PubMed ID: 17520321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An anti-viral peptide derived from the preS1 surface protein of hepatitis B virus.
    Kim DH; Ni Y; Lee SH; Urban S; Han KH
    BMB Rep; 2008 Sep; 41(9):640-4. PubMed ID: 18823587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
    Gallina A; Gazina E; Milanesi G
    Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes.
    Meier A; Mehrle S; Weiss TS; Mier W; Urban S
    Hepatology; 2013 Jul; 58(1):31-42. PubMed ID: 23213046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry.
    Sun Y; Wang S; Yi Y; Zhang J; Duan Z; Yuan K; Liu W; Li J; Zhu Y
    Front Cell Infect Microbiol; 2018; 8():338. PubMed ID: 30319994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TIMM29 interacts with hepatitis B virus preS1 to modulate the HBV life cycle.
    Muriungi NG; Ueda K
    Microbiol Immunol; 2020 Dec; 64(12):792-809. PubMed ID: 32970362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection.
    Gerken G; Kremsdorf D; Capel F; Petit MA; Dauguet C; Manns MP; Meyer zum Büschenfelde KH; Brechot C
    Virology; 1991 Aug; 183(2):555-65. PubMed ID: 1853561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes.
    Neurath AR; Kent SB; Strick N; Parker K; Courouce AM; Riottot MM; Petit MA; Budkowska A; Girard M; Pillot J
    Mol Immunol; 1987 Sep; 24(9):975-80. PubMed ID: 3657811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
    Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
    Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of semi-enveloped particles as a unique feature of a hepatitis B virus PreS1 deletion mutant.
    Jiang B; Wu Q; Kuhnhenn L; Akhras S; Spengler C; Boller K; Peiffer KH; Hildt E
    Aliment Pharmacol Ther; 2019 Oct; 50(8):940-954. PubMed ID: 31240738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus preS1 functions as a transcriptional activation domain.
    Kim HS; Ryu CJ; Hong HJ
    J Gen Virol; 1997 May; 78 ( Pt 5)():1083-6. PubMed ID: 9152426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus.
    Neurath AR; Kent SB; Strick N; Parker K
    Cell; 1986 Aug; 46(3):429-36. PubMed ID: 3015414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection.
    Li X; Qin Y; Liu Y; Li F; Liao H; Lu S; Qiao Y; Xu D; Li J
    J Clin Virol; 2016 Sep; 82():27-32. PubMed ID: 27415434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
    Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
    Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
    Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
    J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor.
    Budkowska A; Quan C; Groh F; Bedossa P; Dubreuil P; Bouvet JP; Pillot J
    J Virol; 1993 Jul; 67(7):4316-22. PubMed ID: 8510225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A monoclonal antibody specific for the hepatocyte receptor binding site on hepatitis B virus.
    Petit MA; Dubanchet S; Capel F
    Mol Immunol; 1989 Jun; 26(6):531-7. PubMed ID: 2475766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cellular protein which binds hepatitis B virus but not hepatitis B surface antigen.
    Harvey TJ; Macnaughton TB; Park DS; Gowans EJ
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():607-615. PubMed ID: 10091999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Display of hepatitis B virus PreS1 peptide on bacteriophage T7 and its potential in gene delivery into HepG2 cells.
    Tang KH; Yusoff K; Tan WS
    J Virol Methods; 2009 Aug; 159(2):194-9. PubMed ID: 19490973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor-mediated entry of hepatitis B virus particles into liver cells.
    Treichel U; Meyer zum Büschenfelde KH; Dienes HP; Gerken G
    Arch Virol; 1997; 142(3):493-8. PubMed ID: 9349295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.